Mastectomy
Medical Author:
Leigh A Neumayer, MD, MS, FACS
Medical Editor:
Melissa Conrad Stöppler, MD, Chief Medical Editor
Melissa Conrad Stöppler, MD, Chief Medical EditorMelissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.
Mastectomy OverviewMastectomy is an operation in which the entire breast, usually including the nipple and the areola, is removed. Mastectomy is usually performed as a treatment of breast cancer. In general, women with breast cancer can decide whether to be treated with a lumpectomy or a mastectomy. A lumpectomy is the removal of the cancerous breast tissue as well as a surrounding rim of healthy breast tissue. A lumpectomy is a breast-conserving surgery that is usually followed by radiation therapy (high-dose X-rays or other high-energy rays to kill cancer cells). A woman may decide to have a mastectomy versus a lumpectomy based on the following:
If the woman has tumors in more than one quadrant of the breast, most cancer doctors recommend a mastectomy. Historically, a mastectomy for breast cancer included an axillary lymph node dissection (removal of many of the axillary lymph nodes). Over the last decade, the approach has changed slightly in that many women can undergo a sentinel lymph node biopsy (removal of the first few lymph nodes draining the tissue of the breast) rather than an axillary lymph node dissection. The nomenclature is such that a modified radical and a radical mastectomy include an axillary lymph node dissection as part of the overall procedure. With the adoption of sentinel lymph node biopsy in the treatment of early breast cancer, the nomenclature for mastectomy has also changed. Depending on the characteristics of the tumor, the breast, and the patient, the surgeon may choose one of the following types of mastectomies:
In general, if leaving the skin of the areola and or nipple, some surgeons recommend that the woman have a tumor that is less than 2 centimeters in size and that is more than 2 centimeters away from the nipple. The skin-sparing mastectomies are ideal for patients undergoing prophylactic mastectomy. The skin-sparing, nipple-sparing, and total skin-sparing mastectomies are generally done in combination with immediate breast reconstruction. The benefit of these procedures is that more of the breast skin envelope is preserved to make it easier to recreate the breast. No randomized trial has been undertaken to evaluate if there is an increased risk of local (in the breast skin or on the muscle) recurrence with the skin-sparing techniques. Most surgeons estimate that preserving more skin increases the risk of local recurrence of the tumor by 1% or 2 % over 20 years (from 3%-5% for traditional to 5%-7% for skin-sparing).
Viewer Comments & ReviewsMastectomy - CausesThe eMedicineHealth physician editors ask:What was the cause of you needing a mastectomy? |
Breast Cancer
Find support and advances in treatment.
From WebMD
Cancer Resources
Featured Centers
- Ask the Nutritionist: Weight Loss Tips
- Which Drugstore Tooth Whiteners Work Best?
- Gout: Symptoms, Causes, and Treatments
Health Solutions From Our Sponsors
Mastectomy
Breast Cancer Overview
Breast cancer is cancer arising in breast tissue. Cancer is simply a group of abnormal cells that have abnormal growth patterns.
- Although breast cancer is primarily a disease of women, about 1% of breast cancers occur in men.
- Breast cancer is the most common type of cancer in women with the exception of nonmelanoma skin cancers. It is the second leading cause of death by cancer in women, following only lung cancer.
- In 2011, the American Cancer Society estimated that 230,480 new cases of invasive breast cancer would be diagnosed among women in the United States and that a further 57,650 new cases of in-situ (noninvasive) breast cancer would be diagnosed.
- A woman has a lifetime risk of developing invasive breast cancer of about one in eight, or 13%.
- Death rates from breast cancer have been gradually declining and continue to decline. These decreases are likely due both to increa...
Read What Your Physician is Reading on Medscape
Breast Cancer »
Breast cancer is the most common cancer and the second most common cause of death from cancer in women.
Featured Topics
Medical Dictionary
Pill Identifier on RxList
- quick,
easy,
pill identification
Find a Local Pharmacy
- including
24 hour
pharmacies

